HIGHLIGHTS
- who: Anaïs Huwart from the (UNIVERSITY) have published the research work: Ultrasonography and magnetic resonance imaging changes in patients with polymyalgia rheumatica treated by tocilizumab, in the Journal: (JOURNAL)
- what: Background: This study assessed inflammatory changes using ultrasound (US) and magnetic resonance imaging (MRI) in patients taking tocilizumab for polymyalgia rheumatica (PMR). TCZ is an emerging treatment for PMR, and the study provides the first data about its effects on imaging study abnormalities.
- how: Similar results were obtained with a TCZ-corticosteroid combination . The authors conducted a prospective cross-sectional multicenter study . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.